A ‘ severe level two’ cluster. Characterised by headache, loss of smell, loss of appetite, cough, fever, hoarseness, sore throat, chest pain, fatigue, confusion, muscle pain.A ‘severe level one’ cluster. Characterised by headache, loss of smell, cough, fever, hoarseness, chest pain, fatigue.A ‘ gastrointestinal’ cluster. Characterised by headache, loss of smell, loss of appetite, diarrhoea, sore throat, chest pain, no cough.A ‘flu-like’ cluster with fever. Characterised by headache, loss of smell, cough, sore throat, hoarseness, fever, loss of appetite.A ‘flu-like’ cluster with no fever. Characterised by headache, loss of smell, muscle pain, cough, sore throat, chest pain.By analysing a subset of 1653 app users in the UK and US with confirmed COVID-19, the COVID Symptom Study recently identified six clusters of COVID-19 symptoms. Researchers behind the app suggested that the following symptom clusters could be used as a potential clinical prediction tool: They manifest in older patients or those who have a weaker immune system, often in the absence of a fever.Ī COVID Symptom Tracker app developed by King’s College London, Guy’s and St Thomas’ NHS Foundation Trust, their NIHR Biomedical Research Centre and the healthcare start-up ZOE is currently monitoring 4 million users across the UK, the US and Sweden. atypical symptoms, such as delirium and reduced mobility.non-specific symptoms, such as muscle pain, sore throat, headache, nasal congestion, diarrhoea, nausea and vomiting.more common symptoms, such as fever cough shortness of breath fatigue loss of appetite, smell or taste.Guidance from Public Health England describes the following: However, there is emerging evidence supporting a more complex range of clinical features of SARS-CoV-2 infection. ![]() COVID-19 symptoms: what are they?Īs described on the NHS website, the main symptoms of SARS-CoV-2 infection are: 1) a high temperature, 2) a new, continuous cough, and 3) a loss or change of smell or taste. This article summarises the current understanding of acute and long-term COVID-19 symptoms, and the increasing evidence on the long-term effects of COVID-19 on different systems. Over the course of the pandemic it has emerged that SARS-CoV-2 is not only a respiratory virus, but is able to affect many other organs, such as the heart, brain and kidneys. Research on the clinical manifestations of SARS-CoV-2 infection is still ongoing. ![]() You can view all our reporting on this topic under COVID-19. The article will be updated as the research progresses. ![]() This is part of our rapid response content on COVID-19.UK-based initiatives, such as the post-hospitalisation COVID-19 (PHOSP-COVID) study and the Research and Innovation for post-COVID-19 Rehabilitation (RICOVR), are currently investigating the long-term effects of COVID-19 and its rehabilitation.Long-term cohort studies are needed to better understand long-term disease consequences in COVID-19 patients.There is emerging evidence on the long-term health effects of COVID-19. These include long-term respiratory complications, thrombosis, heart failure, kidney injury, fatigue, joint and muscle pain, and metabolic abnormalities.Patient-led initiatives, such as the Patient-Led Research Team or Long COVID SOS, are conducting research and campaigns to support the recognition of the debilitating effects of ‘long COVID’.These include fatigue, difficulties in thinking, shortness of breath, chest pain, irregular or abnormal heart rhythm, and joint pain. ‘Long-haulers’ are patients who experience ongoing COVID-19 symptoms for several months after infection.There is emerging evidence that COVID-19 affects many systems of the body, with patients reporting a wide range of symptoms.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |